Transactions
7
Insider / CVS HEALTH Corp
CAPOZZI HEIDI B
EVP and Chief People Officer at CVS HEALTH Corp
- Company
- CVS HEALTH Corp
- Ticker
- CVS
- First filing on record
- October 14, 2025
- Latest trade on record
- April 1, 2026
- SEC filings
- EDGAR ↗
CAPOZZI HEIDI B, EVP and Chief People Officer at CVS HEALTH Corp, has disclosed 7 transactions in CVS since October 14, 2025: 3 purchases (3 open-market buys) and 2 sales, worth about $6.2M at the reported prices. The latest was filed April 2, 2026, 2 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
3
Sales
2
Avg. disclosure lag
162.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months CAPOZZI HEIDI B made no purchases and 2 sales worth $858K, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
CAPOZZI HEIDI B has traded 1 stock on record; the largest by dollars is CVS.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| P | Open-market purchase | 3 | 80 | $4,589 |
| A | Grant or award | 2 | 74,695 | $5.4M |
| F | Shares withheld for tax | 2 | 10,804 | $858K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 1 · $97K |
| 2025 | 1 | 0 | 1 · $761K |
| 2024 | 3 | 3 · $4,589 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS | Other A | March 31, 2026 | April 2, 2026 | 2d | 64,670 | $72 | $4.6M | derivative | Form 4 ↗ | |
| CVS | Sell F | April 1, 2026 | April 2, 2026 | 1d | 1,334 | $72 | $97K | Form 4 ↗ | ||
| CVS | Other A | March 31, 2026 | April 2, 2026 | 2d | 10,025 | $72 | $720K | Form 4 ↗ | ||
| CVS | Sell F | November 30, 2025 | December 2, 2025 | 2d | 9,470 | $80 | $761K | Form 4 ↗ | ||
| CVS | Buy P | October 23, 2024 | October 14, 2025 | 356d | 35 | $57 | $1,990 | lateindirect | Form 4 ↗ | |
| CVS | Buy P | October 2, 2024 | October 14, 2025 | 377d | 10 | $62 | $622 | lateindirect | Form 4 ↗ | |
| CVS | Buy P | September 9, 2024 | October 14, 2025 | 400d | 35 | $56 | $1,976 | lateindirect | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| April 2, 2026 | Form 4 | 0000064803-26-000035 | 3 | published | EDGAR ↗ |
| December 2, 2025 | Form 4 | 0000064803-25-000069 | 1 | published | EDGAR ↗ |
| October 14, 2025 | Form 4 | 0000064803-25-000031 | 3 | published | EDGAR ↗ |
Other insiders at CVS HEALTH Corp
- Mahoney Michael F Chairman, President & CEO 30 rows
- KIRBY J SCOTT Director 20 rows
- Finucane Anne A. Director 18 rows
- AGUIRRE FERNANDO Director 13 rows
- Newman Brian Director 10 rows
- ROBBINS LARRY Director 10 rows
- FARAH ROGER N Director 9 rows
- Clark James David SVP, Cont & Chief Acct Officer 5 rows
- Mandadi Tilak EVP, Chief Exp & Tech Officer 5 rows
- Norwalk Leslie V Director 5 rows
Everyone on file, with contracts and lobbying under the company's name: CVS HEALTH Corp.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 7 | October 14, 2025 | April 2, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.